If you have this stock then sell all to them but small fish pls avoid spend your hard-earned money on it even if the price dropped. This stock only valued around 10 cents.
Of course limit up!!!!!!! History will repeat due to the characteristics and style of the boss! It shot up crazily last time from 1.38 on 26 Nov 2010 to 5.68 on 2 Dec 2010 just within one week time!!!!!!!!!!!
If you still behave like chicken bola, behave like outdated investors which still have fikiran kolot, still doubtful whether this project will succeed or not, then you will miss the boat!!!!!
Remember! This is New Normal now! The patterns of trading in stock exchange, not only in Malaysia, but also in all over the worldwide, have been changed!!!!!!! So, in order to earn more money in stock market, we must change our thinking and patterns and style!!!!! So wait for what? Just GORENG first if it has prospect!!!!!!!
KUALA LUMPUR, Aug 6 -- Ho Wah Genting Bhd (HWGB), through its wholly-owned subsidiary, HWGB Biotech Sdn Bhd (HWGB Biotech), has signed a Memorandum of Agreement (MoA) with US-based E-MO Biology Inc (EBI) to undertake research on COVID-19 patent applications.
In a statement today, HWGB said EBI, had on June 15, 2020, submitted the Initial Investigational New Drug (IND) application to the United States Food and Drug Administration (FDA) to conduct phase IV clinical trials for a new indication, which proposed the use of existing poliomyelitis virus vaccines (polio vaccines) for prevention of COVID-19, which is currently pending approval.
HWGB chief executive officer Datuk Lim Ooi Hong said the proposed collaboration is expected to contribute positively to the earnings of HWGB upon commercialisation of the vaccines.
"The proposed collaboration will see HWGB investing USD$1 million (RM4.18 million) into EBI, entitling the company to 40 per cent of the total profit from the commercialised vaccine.
"HWGB will also have exclusive rights for the production, distribution and sale of the repurposed vaccine based on the polio vaccine for use in preventing COVID-19 infections in Southeast Asian countries," he said.
In addition, HWGB will have the right to retain all profits from the vaccines, as well as a royalty-free licence together with the granting of sub-licences for the use of the trademark and other intellectual property rights in relation to the vaccines in Southeast Asian countries.
EBI sole director and shareholder Professor Qiyi Xie said by having HWGB Biotech on board, the company would be able to penetrate the SEA countries as soon as the vaccines are made available to the market.
Beware of this loh chin stock...if not bomba need to prepare safety tools to save your life !!
DO NOT invest in HO WAH GENTING BHD for its Covid19 vaccine work.
What they are doing is to see if the polio vaccine is protective against the Covid19. I can tell everyone right now the polio vaccine is not protective against Covid19.
How do I know that?
1 - Polio is a different virus from Covid19. 100% different virus. Vaccines are very specific and so is the immune system.
2. All Malaysians have been vaccinated against polio as children. Most people around the world have also been vaccinated against polio.And guess what, we still catch Covid19. If the polio vaccine had any protective ability, nobody is Asia, Africa and most of America would not have caught Covid19.
3. I have the correct training to professional call a stupid biomedical idea, idiotic..This is as idiotic as the people trying to see if the BCG vaccine works against Covid19, it doesn't!
Retail investors, AVOID Ho Wah Genting! Their attempt at using the polio vaccine as SARS-Cov2 vaccine will NEVER work.
Ho Wah Genting management if you are reading this, stop f-ing around. You are dragging the Genting name through the mud. You should be ashamed of yourselves!
If you want to make a vaccine against Covid19, do so properly. I know you are not a biotech company and don't have great technical experties, you are a cables and transportation company. So here is some general advice from someone who has worked at the NIH, make an inactivated viral vaccine. It isn't anymore difficult than growing the SARS-COv2 virus in cell culture, harvesting the virus, concentrating it either by ultracentrifugation or making a modified virus and purifying it on a binding column and inactivating the virus with formaldehyde. You can gamma irradiate for extra safety.
Ayo sign MOU and pay $1mil USD think can become vaccine player liao ah? Want to goreng up the stocks also do it properly la.
1. When you sign MOU like this and so obvious with 40% profit etc. This show u are an unethical company. 2. $1mil USD to secured the rights? Well thats because the company also dont even know their vaccine will succeed or not. Vaccine need billions to developt like J&J, Moderna, etc. 3. Any bulk purchase or vaccine will be by the government and company. Not individual company like this. Then government will assign local company for bottling and etc. Probably when everybody get their dose then small company like this Ho Wah will get a chance.
So, signing MOU only trap uncle and aunties to this unethical counter.
This Year 2020 HWGB has made three agreement - This is worth RM5.00 in future
1. MOA AUTHORISATION AS GENERAL DISTRIBUTOR OF SANSURE BIOTECH INC. TO PROMOTE ANDPUBLICIZE THE COVID-19 NUCLEIC ACID DETECTION KITS AND INSTRUMENTS IN MALAYSIA 2. MOA HO WAH GENTING BERHAD (HWGB OR THE COMPANY)AGREEMENT ENTERED INTO BETWEEN TWINOXIDE SOUTHEAST ASIA SDN BHD AND DVIRIA NANO TECH SDN BHD (FORMERLY KNOWN ASREX ORIENTAL SDN BHD), A WHOLLY OWNED SUBSIDIARY OF HWGB 3. MOA MEMORANDUM OF AGREEMENT ENTERED INTO BETWEEN HWGB BIOTECH SDN BHD AND E-MOBIOLOGY INC. Related to Vaccine COVID-19
=MARKET BUZZ: Malaysia's Pharmaniaga, Duopharma Biotech Climb On Vaccine Newsflow
Pharmaniaga gains 7.6% to MYR4.79 while Duopharma Biotech climbs more than 10% to MYR3.18 as news about Covid-19 vaccine continues to flow; Ho Wah Genting extends gain, surging 10% to MYR1.32 following announcement that the wires-and-cables company is seeking to venture into vaccine business. “Pharmaceutical is now the most exciting sector of the market,” analyst with local brokerage. Notes, some investors are rotating funds out of technology sector and into vaccine-related stocks to take advantage of strong, but likely short-term, uptrend in the sector. Adds, pharmaceutical as a business generally has long gestation, requiring heavy capital investment for research in tightly-regulated environment, making the sector highly risky for equities market.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
greedy44444
2,497 posts
Posted by greedy44444 > 2020-08-09 09:06 | Report Abuse
Nothing yet to show but prices already limit up...not a trapped then surely it's a loh chin stock